Loading the security page…
A security analysis is not yet prepared for this market.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Assembly Biosciences, Inc. (ASMB) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Assembly Biosciences, Inc. (ASMB) on November 9, 2026 is 21.46 $, +5.12 % on the day. Over 52 weeks the stock traded between 19.25 $ and 39.71 $; the price now sits 11 % of the way up that range. Over the past year the price changed by −37.17 %. Market capitalization is 227.40 million $, rank 196 among 381 stocks of the same industry with a known capitalization.
Assembly Biosciences, Inc. trades on Nasdaq under the ticker ASMB. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks ASMB has traded between 19.25 $ and 39.71 $. As of 9 November 2026 the price stood 1.27% of the way from the 52-week low to the high.
Over one year ASMB shares fell 37.17%; over six months they fell 29.87%. Volatility over 90 days is 60.62%. Dividends are not included: this is price change only, as of 9 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 3.0, below the sector median of 3.6. Price to book is 0.7, below the sector median of 2.3. Calculated from reports for the period ending 30 June 2026.
Assembly Biosciences, Inc. reported revenue of 75M $ and a net loss of 42,000 $ over the last four quarters. Net margin is −0.06%. Revenue changed by +125.12% year over year. Earnings per share are $1.24. Market capitalisation is 227M $.
ASMB has a return on equity of −0.01%, above the sector median of −40.58%. Return on assets is −0.01%, above the sector median of −30.08%. Operating margin is −11.75%, above the sector median of −20.96%.